Thrombolysis in acute myocardial infarction. The implementation of thrombolytic therapy in a coronary care unit in 1992.
In order to describe the execution of thrombolytic therapy in acute myocardial infarction (AMI) in a coronary care unit, case records of 427 admissions in 1992 due to definite or possible AMI were reviewed: 32% received thrombolytic therapy while 68% did not because of contraindications, delayed admission, advanced age or nondiagnostic ECG changes. Among cases otherwise eligible for thrombolytic therapy according to the instructions of the department, 32% did not receive thrombolytic treatment solely because of nondiagnostic ECG changes. There is an obvious need for implementation of improved early diagnostic tools in the decision-making of thrombolysis as for instance newer, sensitive biochemical markers and continuous vectocardiography.
Haastrup
B
B
Department of Cardiology, Odense University Hospital, Denmark.
Gill
S
S
Haghfelt
T
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000075202:Contraindications; D003325:Coronary Care Units; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D013300:Streptokinase / Q000008:administration & dosage; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage
D013300:Streptokinase; D010959:Tissue Plasminogen Activator